Zobrazeno 1 - 2
of 2
pro vyhledávání: '"D. A. K. C. J. M. Huijsmans"'
Autor:
P. T. R. Rodrigus, Paul Lips, D. A. K. C. J. M. Huijsmans, O. S. Hoekstra, C. Dragoiescu, J. L.P. Kuijpens, M. A. B. D. Plaizier, Jan Willem Coebergh, J. G. Ribot, Gerrit J.J. Teule, D. J. Kuik
Publikováno v:
Clinical Endocrinology. 58:451-455
Summary BACKGROUND Justification for adjuvant radio-iodine (I-131) therapy in differentiated thyroid cancer (DTC) is purely based on retrospective data. This is true for ablative therapy and even more so for high-dosage adjuvant schedules. Randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c56bb9f737aea3e90ddad9b6c8bcb635
https://doi.org/10.1046/j.1365-2265.2003.01738.x
https://doi.org/10.1046/j.1365-2265.2003.01738.x
Autor:
C, Dragoiescu, O S, Hoekstra, D J, Kuik, P, Lips, M A B D, Plaizier, P T R, Rodrigus, D A K C J M, Huijsmans, J G, Ribot, J, Kuijpens, J W W, Coebergh, G J J, Teule
Publikováno v:
Clinical endocrinology. 58(4)
Justification for adjuvant radio-iodine (I-131) therapy in differentiated thyroid cancer (DTC) is purely based on retrospective data. This is true for ablative therapy and even more so for high-dosage adjuvant schedules. Randomized trials on the latt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96fc8a1054ec964901b0412a35ac3818
https://pubmed.ncbi.nlm.nih.gov/12641628
https://pubmed.ncbi.nlm.nih.gov/12641628